Schall Law Firm Investigates Adverum Biotechnologies for Potential Securities Violations
The Schall Law Firm, a national litigation firm focused on shareholder rights, is currently investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or “the Company”) ADVM regarding potential violations of securities laws.
This investigation centers on whether Adverum issued false or misleading statements, or failed to disclose crucial information impacting investors. On March 31, 2025, the Company filed an SEC report stating that “certain of the Company’s previously issued financial statements should no longer be relied upon due to non-cash errors identified in the accounting for tenant improvement allowances associated with an operating lease and sublease related to a building in North Carolina (the ‘NC Premises’).” Following this announcement, Adverum revealed its intention to restate financial statements for the years ended December 31, 2022, and 2023, as included in its Annual Report on Form 10-K for the year ended December 31, 2023, and for unaudited condensed consolidated quarterly financial information for periods in 2023 and 2024. As a result, shares of Adverum saw a drop of more than 12% on April 1, 2025.
If you are a shareholder who has incurred a loss, click here to participate in the investigation.
Shareholders are encouraged to reach out to Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. He can be contacted at 310-301-3335 for a free discussion about your rights. Additionally, you can visit the firm’s website at www.schallfirm.com or email [email protected].
The Schall Law Firm focuses on representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions according to applicable laws and ethics rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250413064731/en/
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com
Market News and Data brought to you by Benzinga APIs